ABOUT

MYELOID

At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies and unleash the power of myeloid cells in cancer.

​

Our proprietary ATAK™ platform is designed to designed to turn myeloid cells against tumors. These engineered cells find, recognize and penetrate tumors. These cells also prime other elements of the immune system, including T cells, thereby reinforcing the anti-tumor immune response, culminating in cancer eradication.   

AdobeStock_18058273 cube_fnl_lo.png

THE

Myeloid is powered by the discoveries of our founders – a group of world-leading scientists whose expertise spans oncology, immunology, mRNA biology, cell therapy, synthetic biology, and gene delivery.

 

We’re building a team of talented, driven scientists and other biotech industry experts to turn these discoveries into novel, life-saving treatments for people navigating life with cancer.

 

TEAM

LEADERSHIP

DarrenBaccia34_Real_lo.png
DarrenBaccia34_silhouette_lo.png

Chief Business Officer

Darren Braccia

MicheleGerber15_web_Silhouette_real_lo c
MicheleGerber15_web_Silhouettelo copy.pn

MD, MPH

Chief Medical Officer

Michele Gerber

bruce_Rng_silhouette.png

Chief Science Officer

Bruce McCreedy, PhD

E Jones Mar 2020_12-cutout.png

Board Director

Elaine Jones

PhD

TCahill1_Silhouette_Lo.png

President; Newpath Partners

Thomas Cahill

MD PhD

MBA, PhD

Chief Executive Officer

Daniel Getts

Yuxiao_cutout.png

Co-Founder

Yuxiao Wang
PhD

FOUNDERS

MD Phil

Founder & Chair - Advisory Board

Siddhartha Mukherjee
Ronald-Vale-400x400_adjust_cutout.png
Ronald_Vale_Silhouette.png

Founder

Ronald Vale, PhD

FOUNDERS
LEADERSHIP

Daniel Getts

Chief Executive Officer

Bruce McCreedy, PhD

Chief Science Officer

Elaine Jones, PhD

Board Director

Darren Braccia

Chief Business Officer

Sadettin Ozturk, PhD

Chief Technology & Manufacturing Officer 

Thomas Cahill, MD, PhD

Co-Founder and President

Michele Gerber, MD, MPH

Chief Medical Officer

Michele Cioffi

VP, Clinical Operations

Ronald Vale, PhD

Founder

Siddhartha Mukherjee,
MD, DPhil

Founder & Chair of Advisory Board

Yuxiao Wang, PhD

Co-founder & Sr. Director,

Discovery Research

FOUNDERS

Ronald Vale, PhD

Founder

Siddhartha Mukherjee,
MD, DPhil

Founder & Chair of Advisory Board

Yuxiao Wang, PhD

Co-founder & Sr. Director,

Discovery Research

NewpathLogo_lo.png
ARE_Proprietary_Products_RGB_VentureInve
hatteraslogos-rev_new_400 copy.png
8VC-logo-black.png
INVESTORS

SCIENTIFIC ADVISORY BOARD

Frequently asked questions

#demo.question.question1#

#demo.question.question1.answer1#



#demo.question.question2#

#demo.question.question2.answer1#

  1. #demo.question.question2.answer2#
  2. #demo.question.question2.answer3#
  3. #demo.question.question2.answer4#
  4. #demo.question.question2.answer5#



#demo.question.question3#

#demo.question.question3.answer0#

  1. #demo.question.question3.answer1#
  2. #demo.question.question3.answer2#
  3. #demo.question.question3.answer3#
  4. #demo.question.question3.answer4#
  5. #demo.question.question3.answer5#



#demo.question.question4#

#demo.question.question4.answer1#



Clinical Cell

Therapy Advisors

Frequently asked questions

#demo.question.question1#

#demo.question.question1.answer1#



#demo.question.question2#

#demo.question.question2.answer1#

  1. #demo.question.question2.answer2#
  2. #demo.question.question2.answer3#
  3. #demo.question.question2.answer4#
  4. #demo.question.question2.answer5#



#demo.question.question3#

#demo.question.question3.answer0#

  1. #demo.question.question3.answer1#
  2. #demo.question.question3.answer2#
  3. #demo.question.question3.answer3#
  4. #demo.question.question3.answer4#
  5. #demo.question.question3.answer5#



#demo.question.question4#

#demo.question.question4.answer1#



Immunology, Virology & Myeloid Cell Advisors